Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2025 年第 4 季持倉
持倉截至 2025/12/31，2026/2/13 申報。只含多頭部位，變化是跟 2025 年第 3 季比股數。
- 持股檔數
- 86
- 較 2025 年第 3 季 0
- 總值
- $13.9 億
- 較 2025 年第 3 季 +$3.17 億 (+29.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| APGEApogee Therapeutics, Inc. | COM | 1,234,926 | $9,321 萬 | 6.7% | +61,500+5.2% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 450,000 | $7,832 萬 | 5.6% | 00.0% | 不變 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 505,000 | $6,810 萬 | 4.9% | +145,000+40.3% | 加碼 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 6,484,558 | $5,856 萬 | 4.2% | +2,560,143+65.2% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,250,000 | $5,603 萬 | 4.0% | −150,000−10.7% | 減碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 185,000 | $5,453 萬 | 3.9% | +185,000 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 800,000 | $5,083 萬 | 3.7% | +450,000+128.6% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,432,591 | $4,693 萬 | 3.4% | +13,292+0.9% | 加碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 2,700,000 | $4,590 萬 | 3.3% | +600,000+28.6% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $4,369 萬 | 3.1% | 00.0% | 不變 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 1,700,000 | $3,689 萬 | 2.7% | +900,000+112.5% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 523,725 | $3,415 萬 | 2.5% | +23,725+4.7% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 322,633 | $3,245 萬 | 2.3% | −61,784−16.1% | 減碼 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 3,200,000 | $3,178 萬 | 2.3% | −670,527−17.3% | 減碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,000,000 | $2,798 萬 | 2.0% | −250,000−20.0% | 減碼 | 歷史 |
| FBRXForte Biosciences, Inc. | COM NEW | 989,490 | $2,698 萬 | 1.9% | +989,490 | 新進 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 2,150,172 | $2,692 萬 | 1.9% | −649,828−23.2% | 減碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 730,000 | $2,649 萬 | 1.9% | −20,000−2.7% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 320,000 | $2,448 萬 | 1.8% | +255,000+392.3% | 加碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 802,342 | $2,432 萬 | 1.7% | −156,838−16.4% | 減碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 550,000 | $2,222 萬 | 1.6% | +550,000 | 新進 | 歷史 |
| ANABAnaptysbio, Inc | COM | 444,692 | $2,156 萬 | 1.5% | +444,692 | 新進 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 1,932,106 | $2,000 萬 | 1.4% | +1,668,289+632.4% | 加碼 | 歷史 |
| Omeros Corp682143AK8 | NOTE 9.500% 6/1 | – | $1,938 萬 | 1.4% | – | – | – |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 1,051,054 | $1,909 萬 | 1.4% | +44,837+4.5% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 967,620 | $1,836 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 3,300,000 | $1,815 萬 | 1.3% | +300,000+10.0% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 31,131 | $1,813 萬 | 1.3% | −83,869−72.9% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 2,797,153 | $1,687 萬 | 1.2% | +1,297,153+86.5% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 172,125 | $1,503 萬 | 1.1% | −48,475−22.0% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 600,552 | $1,502 萬 | 1.1% | −506,610−45.8% | 減碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 200,000 | $1,458 萬 | 1.0% | −110,000−35.5% | 減碼 | 歷史 |
| ERASErasca, Inc. | COM | 3,900,000 | $1,451 萬 | 1.0% | −385,787−9.0% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 250,000 | $1,266 萬 | 0.9% | −53,330−17.6% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 350,000 | $1,243 萬 | 0.9% | +350,000 | 新進 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 7,150,000 | $1,165 萬 | 0.8% | +4,500,000+169.8% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 300,000 | $1,146 萬 | 0.8% | −200,000−40.0% | 減碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 714,956 | $1,103 萬 | 0.8% | +649,639+994.6% | 加碼 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $998.9 萬 | 0.7% | – | – | – |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 275,000 | $964.7 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 350,000 | $950.6 萬 | 0.7% | +50,000+16.7% | 加碼 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 1,813,671 | $950.4 萬 | 0.7% | +539,320+42.3% | 加碼 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 1,000,000 | $886.0 萬 | 0.6% | +1,000,000 | 新進 | 歷史 |
| STROSutro Biopharma, Inc. | COM SHS | 748,382 | $865.9 萬 | 0.6% | +673,110+894.2% | 加碼依 1 比 10 拆股換算 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 100,000 | $796.5 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 250,000 | $788.5 萬 | 0.6% | +85,000+51.5% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 250,000 | $778.0 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 300,000 | $714.9 萬 | 0.5% | +300,000 | 新進 | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 1,148,245 | $679.8 萬 | 0.5% | +798,245+228.1% | 加碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 889,575 | $654.7 萬 | 0.5% | +889,575 | 新進 | 歷史 |
| Celcuity Inc.15102KAA8 | NOTE 2.750% 8/0 | – | $651.6 萬 | 0.5% | – | – | – |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 30,000 | $639.7 萬 | 0.5% | +30,000 | 新進 | 歷史 |
| VRCAVerrica Pharmaceuticals Inc. | COM SHS | 707,338 | $587.8 萬 | 0.4% | +707,338 | 新進 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 643,370 | $581.0 萬 | 0.4% | +566,370+735.5% | 加碼 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 245,000 | $563.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 2,351,144 | $554.9 萬 | 0.4% | +251,144+12.0% | 加碼 | 歷史 |
| AVDLAvadel Pharmaceuticals PLC | Stock | 250,000 | $538.8 萬 | 0.4% | +250,000 | 新進 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,300,000 | $520.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IMVTImmunovant, Inc. | COM | 200,000 | $508.4 萬 | 0.4% | −100,000−33.3% | 減碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 2,454,278 | $495.8 萬 | 0.4% | −1,145,722−31.8% | 減碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 115,000 | $473.9 萬 | 0.3% | −147,100−56.1% | 減碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 70,000 | $464.7 萬 | 0.3% | +70,000 | 新進 | 歷史 |
| IBIOiBio, Inc. | COM NEW | 2,057,200 | $397.0 萬 | 0.3% | +2,057,200 | 新進 | 歷史 |
| NXTCNextCure, Inc. | COM NEW | 247,294 | $350.9 萬 | 0.3% | +55,412+28.9% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 75,000 | $349.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AMGNAmgen Inc | Stock | 10,000 | $327.3 萬 | 0.2% | +10,000 | 新進 | 歷史 |
| BLTEBelite Bio, Inc | SPONSORED ADS | 20,000 | $319.9 萬 | 0.2% | +20,000 | 新進 | 歷史 |
| AVBPArriVent BioPharma, Inc. | COM | 150,000 | $301.8 萬 | 0.2% | +150,000 | 新進 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COMMON STOCK | 100,000 | $289.3 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| OACCUOaktree Acquisition Corp. III Life Sciences | UNIT 10/04/2029 | 250,000 | $265.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 486,684 | $242.9 萬 | 0.2% | +36,684+8.2% | 加碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 572,804 | $237.7 萬 | 0.2% | −154,468−21.2% | 減碼 | 歷史 |
| EPRXEupraxia Pharmaceuticals Inc. | COM | 300,000 | $226.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| GERNGeron Corp | COM | 1,500,000 | $198.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 75,000 | $172.5 萬 | 0.1% | +75,000 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 229,076 | $144.1 萬 | 0.1% | +229,076 | 新進 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 200,000 | $138.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| QUREuniQure N.V. | SHS | 50,000 | $119.7 萬 | 0.1% | −250,000−83.3% | 減碼 | 歷史 |
| Cogent Biosciences, Inc.19240QAA0 | NOTE 1.625%11/1 | – | $117.6 萬 | 0.1% | – | 新進 | – |
| CATXPerspective Therapeutics, Inc. | COM NEW | 300,000 | $82.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MGNXMacrogenics Inc | COM | 484,308 | $78.0 萬 | 0.1% | +484,308 | 新進 | 歷史 |
| FRNMFreenome, Inc. | CL A ORD SHS | 50,000 | $65.2 萬 | <0.1% | −300,000−85.7% | 減碼 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 145,000 | $58.0 萬 | <0.1% | +145,000 | 新進 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $9.22 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 80,000 | $8.32 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $1,823 | <0.1% | 00.0% | 不變 | – |
選擇權（9 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $1.83 億 | – |
| iShares Tr464287556 | ISHARES BIOTECH | – | $6,751 萬 |
| AMGNAmgen Inc | Stock | – | $4,419 萬 |
| State Street Health Care Select Sector SPDR ETF81369Y209 | ETF | – | $3,870 萬 |
| QUREuniQure N.V. | SHS | – | $1,914 萬 |
| SMMTSummit Therapeutics Inc. | COM | $612.1 萬 | – |
| ABUSArbutus Biopharma Corp | COM | – | $251.0 萬 |
| LENZLENZ Therapeutics, Inc. | COM | $160.0 萬 | – |
| FBRXForte Biosciences, Inc. | COM NEW | – | $61.1 萬 |
2025 年第 3 季之後清倉（22 檔）
2025 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 3 季股數 | 2025 年第 3 季市值 | 2025 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| VRNAVerona Pharma plc | SPONSORED ADS | 625,000 | $6,669 萬 | 6.2% | 歷史 |
| SPYSPDR S&P 500 ETF Trust | ETF | 84,490 | $5,629 萬 | 5.2% | 歷史 |
| MRUSMerus N.V. | COM | 285,769 | $2,691 萬 | 2.5% | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 200,000 | $1,352 萬 | 1.3% | 歷史 |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $1,246 萬 | 1.2% | – |
| ELVNEnliven Therapeutics, Inc. | COM | 400,000 | $818.8 萬 | 0.8% | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 125,000 | $742.9 萬 | 0.7% | 歷史 |
| AKBAAkebia Therapeutics, Inc. | COM | 2,450,000 | $668.9 萬 | 0.6% | 歷史 |
| MNPRMonopar Therapeutics | COM NEW | 79,483 | $649.1 萬 | 0.6% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 125,000 | $450.3 萬 | 0.4% | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 50,000 | $371.0 萬 | 0.3% | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 25,000 | $329.5 萬 | 0.3% | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 1,750,000 | $285.3 萬 | 0.3% | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 239,000 | $279.4 萬 | 0.3% | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 250,000 | $244.8 萬 | 0.2% | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 300,000 | $218.4 萬 | 0.2% | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 5,000 | $209.6 萬 | 0.2% | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 666,666 | $133.3 萬 | 0.1% | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 402,653 | $39.0 萬 | <0.1% | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 200,000 | $35.2 萬 | <0.1% | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 17,998 | $21.4 萬 | <0.1% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 2,500 | $2.51 萬 | <0.1% | 歷史 |